NasdaqGS - Nasdaq Real Time Price USD

Cullinan Therapeutics, Inc. (CGEM)

7.71
+0.21
+(2.80%)
At close: May 19 at 4:00:01 PM EDT
7.71
0.00
(0.00%)
After hours: May 19 at 4:08:59 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-150,211
-145,303
-134,275
-126,664
-43,433
Investing Cash Flow
-112,465
-136,314
35,806
248,975
-333,775
Financing Cash Flow
265,103
266,188
40,751
-25,933
268,784
End Cash Position
76,655
83,005
98,434
156,152
59,774
Income Tax Paid Supplemental Data
--
--
--
37,801
0
Interest Paid Supplemental Data
--
--
--
32
0
Capital Expenditure
--
--
-208
-1,133
--
Issuance of Capital Stock
--
262,652
38,388
0
267,268
Issuance of Debt
--
0
1,825
2,375
0
Repayment of Debt
--
--
0
-2,200
0
Free Cash Flow
-150,211
-145,303
-134,483
-127,797
-43,433
12/31/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DSGN Design Therapeutics, Inc.
3.5300
+0.57%
 
ORIC ORIC Pharmaceuticals, Inc.
5.14
+8.67%
 
OLMA Olema Pharmaceuticals, Inc.
4.8000
+1.91%
 
NUVL Nuvalent, Inc.
73.31
-0.01%
 
ERAS Erasca, Inc.
1.2300
-4.28%
 
IMCR Immunocore Holdings plc
31.00
+2.07%
 
STOK Stoke Therapeutics, Inc.
9.83
+0.72%
 
KYMR Kymera Therapeutics, Inc.
30.20
-0.17%
 
PRAX Praxis Precision Medicines, Inc.
37.35
+0.89%
 
REPL Replimune Group, Inc.
8.20
+4.46%